Cargando…
Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union
Novel microbes are either newly isolated genera and species from natural sources or bacterial strains derived from existing bacteria. Novel microbes are gaining increasing attention for the general aims to preserve and modify foods and to modulate gut microbiota. The use of novel microbes to improve...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601064/ https://www.ncbi.nlm.nih.gov/pubmed/28955311 http://dx.doi.org/10.3389/fmicb.2017.01725 |
_version_ | 1783264320365264896 |
---|---|
author | Brodmann, Theodor Endo, Akihito Gueimonde, Miguel Vinderola, Gabriel Kneifel, Wolfgang de Vos, Willem M. Salminen, Seppo Gómez-Gallego, Carlos |
author_facet | Brodmann, Theodor Endo, Akihito Gueimonde, Miguel Vinderola, Gabriel Kneifel, Wolfgang de Vos, Willem M. Salminen, Seppo Gómez-Gallego, Carlos |
author_sort | Brodmann, Theodor |
collection | PubMed |
description | Novel microbes are either newly isolated genera and species from natural sources or bacterial strains derived from existing bacteria. Novel microbes are gaining increasing attention for the general aims to preserve and modify foods and to modulate gut microbiota. The use of novel microbes to improve health outcomes is of particular interest because growing evidence points to the importance of gut microbiota in human health. As well, some recently isolated microorganisms have promise for use as probiotics, although in-depth assessment of their safety is necessary. Recent examples of microorganisms calling for more detailed evaluation include Bacteroides xylanisolvens, Akkermansia muciniphila, fructophilic lactic acid bacteria (FLAB), and Faecalibacterium prausnitzii. This paper discusses each candidate's safety evaluation for novel food or novel food ingredient approval according to European Union (EU) regulations. The factors evaluated include their beneficial properties, antibiotic resistance profiling, history of safe use (if available), publication of the genomic sequence, toxicological studies in agreement with novel food regulations, and the qualified presumptions of safety. Sufficient evidences have made possible to support and authorize the use of heat-inactivated B. xylanisolvens in the European Union. In the case of A. muciniphila, the discussion focuses on earlier safety studies and the strain's suitability. FLAB are also subjected to standard safety assessments, which, along with their proximity to lactic acid bacteria generally considered to be safe, may lead to novel food authorization in the future. Further research with F. prausnitzii will increase knowledge about its safety and probiotic properties and may lead to its future use as novel food. Upcoming changes in EUU Regulation 2015/2283 on novel food will facilitate the authorization of future novel products and might increase the presence of novel microbes in the food market. |
format | Online Article Text |
id | pubmed-5601064 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56010642017-09-27 Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union Brodmann, Theodor Endo, Akihito Gueimonde, Miguel Vinderola, Gabriel Kneifel, Wolfgang de Vos, Willem M. Salminen, Seppo Gómez-Gallego, Carlos Front Microbiol Microbiology Novel microbes are either newly isolated genera and species from natural sources or bacterial strains derived from existing bacteria. Novel microbes are gaining increasing attention for the general aims to preserve and modify foods and to modulate gut microbiota. The use of novel microbes to improve health outcomes is of particular interest because growing evidence points to the importance of gut microbiota in human health. As well, some recently isolated microorganisms have promise for use as probiotics, although in-depth assessment of their safety is necessary. Recent examples of microorganisms calling for more detailed evaluation include Bacteroides xylanisolvens, Akkermansia muciniphila, fructophilic lactic acid bacteria (FLAB), and Faecalibacterium prausnitzii. This paper discusses each candidate's safety evaluation for novel food or novel food ingredient approval according to European Union (EU) regulations. The factors evaluated include their beneficial properties, antibiotic resistance profiling, history of safe use (if available), publication of the genomic sequence, toxicological studies in agreement with novel food regulations, and the qualified presumptions of safety. Sufficient evidences have made possible to support and authorize the use of heat-inactivated B. xylanisolvens in the European Union. In the case of A. muciniphila, the discussion focuses on earlier safety studies and the strain's suitability. FLAB are also subjected to standard safety assessments, which, along with their proximity to lactic acid bacteria generally considered to be safe, may lead to novel food authorization in the future. Further research with F. prausnitzii will increase knowledge about its safety and probiotic properties and may lead to its future use as novel food. Upcoming changes in EUU Regulation 2015/2283 on novel food will facilitate the authorization of future novel products and might increase the presence of novel microbes in the food market. Frontiers Media S.A. 2017-09-12 /pmc/articles/PMC5601064/ /pubmed/28955311 http://dx.doi.org/10.3389/fmicb.2017.01725 Text en Copyright © 2017 Brodmann, Endo, Gueimonde, Vinderola, Kneifel, de Vos, Salminen and Gómez-Gallego. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology Brodmann, Theodor Endo, Akihito Gueimonde, Miguel Vinderola, Gabriel Kneifel, Wolfgang de Vos, Willem M. Salminen, Seppo Gómez-Gallego, Carlos Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union |
title | Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union |
title_full | Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union |
title_fullStr | Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union |
title_full_unstemmed | Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union |
title_short | Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union |
title_sort | safety of novel microbes for human consumption: practical examples of assessment in the european union |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601064/ https://www.ncbi.nlm.nih.gov/pubmed/28955311 http://dx.doi.org/10.3389/fmicb.2017.01725 |
work_keys_str_mv | AT brodmanntheodor safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion AT endoakihito safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion AT gueimondemiguel safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion AT vinderolagabriel safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion AT kneifelwolfgang safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion AT devoswillemm safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion AT salminenseppo safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion AT gomezgallegocarlos safetyofnovelmicrobesforhumanconsumptionpracticalexamplesofassessmentintheeuropeanunion |